$2 million NIH grant renewal to study hepatitis E virus

For decades, University Distinguished Professor of Molecular Virology X.J. Meng and his lab at the Virginia-Maryland College of Veterinary Medicine have studied hepatitis E virus (HEV), the causative agent of hepatitis E in humans. Now, with a new, five-year National Institutes of Health RO1 grant totaling nearly $2 million — Meng’s third successful competing renewal…

Details

Embryonic microRNA fuels heart cell regeneration, Temple researchers show

(Philadelphia, PA) — By adulthood, the heart is no longer able to replenish injured or diseased cells. As a result, heart disease or an event like a heart attack can be disastrous, leading to massive cell death and permanent declines in function. A new study by scientists at the Lewis Katz School of Medicine at…

Details

UTA working to develop longwave infrared photonic device technology

IMAGE: Robert Magnusson view more  Credit: UT Arlington A research team from The University of Texas at Arlington is working with the Army Research Laboratory to develop nanophotonic devices that could have applications in thermal imaging and resonant filtering. Robert Magnusson, an electrical engineering professor and the Texas Instruments Distinguished University Chair in Nanoelectronics, is the…

Details

Researchers find new mutation in the leptin gene

IMAGE: Leptin, the ‘satiety hormone’ made by adipose cells that helps to regulate energy balance by inhibiting hunger. Opposed by the actions of the hormone ghrelin, the ‘hunger hormone.’ view more  San Antonio, Texas (June 19, 2019) — The global obesity epidemic is so far-reaching it now has an overarching name: globesity. Texas Biomed Staff Scientist…

Details

Reason to present at the 6th Aging Research for Drug Discovery Forum in Basel

IMAGE: Reason, Co-founder and CEO of Repair Biotechnologies; Founder and writer of Fight Aging!, to present at the 6th Aging Research for Drug Discovery Forum in Basel, Switzerland view more  Credit: Insilico Medicine Friday, June 21, 2019 — Today Insilico Medicine, a biotechnology company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence,…

Details

Straight to the heart

IMAGE: The dramatic differences in pressure that occur in the heart influence muscle development, causing cardiomyocytes to have to adapt to their environment. The picture shows human cardiomyocytes that were derived… view more  Credit: Sebastian Diecke, MDC An international team of researchers are seeking to explore the heart at a depth that was previously impossible. They…

Details

Reforming pharmacy benefit manager practices may lead to drug cost savings

IMAGE: Trevor Royce, MD, MS, MPH, is the corresponding author of a perspective in the Journal of the American Medical Associate that highlights the potential impact of unregulated pharmacy benefit manager… view more  Credit: UNC School of Medicine CHAPEL HILL, North Carolina — Efforts to control health care costs in the United States often focus on…

Details

A new drug target for chemically induced Parkinson’s disease

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson’s disease. In a new study led by scientists from the School of Veterinary Medicine, researchers found that an enzyme in the body can metabolize compounds formed in the brain from alkaloids…

Details

Plant-based diet leads to Crohn’s Disease remission, according to case study

Eating a plant-based diet may be an effective treatment for Crohn’s disease, according to a case study published in the journal Nutrients. The case study followed a man in his late 20s who had been diagnosed with Crohn’s disease after experiencing fatigue, bloating, episodic severe abdominal pain, nausea, and occasional ulcers for several years. His…

Details